Nanalysis Scientific Corp. (TSXV:NSCI)

Market Cap	28.87M
Revenue (ttm)	45.50M
Net Income (ttm)	-13.61M
Shares Out	113.22M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	96,480
Average Volume	55,216
Open	0.2550
Previous Close	0.2600
Day's Range	0.2500 - 0.2550
52-Week Range	0.2500 - 0.4850
Beta	0.44
RSI	34.89
Earnings Date	Apr 30, 2025

About Nanalysis Scientific

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Canada, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60 MHz and 100 MHz NMR platform; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides and software products, such as NMRGui...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• CEO: Sean Krakiwsky
• Employees: 249
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NSCI

Financial Performance

In 2024, Nanalysis Scientific's revenue was 45.50 million, an increase of 59.82% compared to the previous year's 28.47 million. Losses were -13.61 million, -15.95% less than in 2023.